Literature DB >> 24402591

Factors associated with vulvodynia incidence.

Barbara D Reed1, Laurie J Legocki, Melissa A Plegue, Ananda Sen, Hope K Haefner, Sioban D Harlow.   

Abstract

OBJECTIVE: To assess incidence rates of and risk factors for vulvodynia.
METHODS: We conducted a longitudinal population-based study of women in southeast Michigan (Woman-to-Woman Health Study) using a validated survey-based screening test for vulvodynia that was repeated at 6-month intervals over 30 months. Unadjusted incidence rates were determined using Poisson models. Demographic and symptom-related risk factors for incidence were assessed using discrete time survival analysis.
RESULTS: Women who screened negative for vulvodynia at baseline and were followed through at least one additional survey (n=1,786) were assessed for onset of vulvodynia. The incidence rate was 4.2 cases per 100 person-years, and rates per 100 person-years were greater in women who were younger (7.6 cases per 100 person-years at age 20 years, compared with 3.3 cases per 100 person-years at age 60 years), Hispanic (9.5 cases per 100 person-years), married, or living as married (4.9 cases per 100 person-years); had reported symptoms of vulvar pain but did not meet vulvodynia criteria on the initial survey (11.5 cases per 100 person-years); or had reported past symptoms suggesting a history of vulvodynia (7.5 cases per 100 person-years). Increased risk of new-onset vulvodynia also included baseline sleep disturbance, chronic pain in general, specific comorbid pain disorders, and specific comorbid psychological disorders.
CONCLUSIONS: The incidence rates of vulvodynia differ by age, ethnicity, and marital status. Onset is more likely among women with previous symptoms of vulvodynia or those with intermediate symptoms not meeting criteria for vulvodynia and among those with pre-existing sleep, psychological, and comorbid pain disorders. This suggests vulvodynia is an episodic condition with a potentially identifiable prodromal phase. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2014        PMID: 24402591      PMCID: PMC3913176          DOI: 10.1097/AOG.0000000000000066

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  28 in total

1.  Provoked vestibulodynia--medical factors and comorbidity associated with treatment outcome.

Authors:  Ulrika Heddini; Nina Bohm-Starke; Kent W Nilsson; Ulrika Johannesson
Journal:  J Sex Med       Date:  2012-02-29       Impact factor: 3.802

2.  painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.

Authors:  Rainer Freynhagen; Ralf Baron; Ulrich Gockel; Thomas R Tölle
Journal:  Curr Med Res Opin       Date:  2006-10       Impact factor: 2.580

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Interstitial cystitis is associated with vulvodynia and sexual dysfunction--a case-control study.

Authors:  Barbara Gardella; Daniele Porru; Rossella E Nappi; Maria Diletta Daccò; Alessia Chiesa; Arsenio Spinillo
Journal:  J Sex Med       Date:  2011-04-07       Impact factor: 3.802

5.  Assessment of vulvodynia symptoms in a sample of U.S. women: a follow-up national incidence survey.

Authors:  Jocelyn T Sutton; Gloria A Bachmann; Lauren D Arnold; George G Rhoads; Raymond C Rosen
Journal:  J Womens Health (Larchmt)       Date:  2008-10       Impact factor: 2.681

6.  Relationship between vulvodynia and chronic comorbid pain conditions.

Authors:  Barbara D Reed; Siobán D Harlow; Ananda Sen; Rayna M Edwards; Di Chen; Hope K Haefner
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

7.  Clinical characteristics and psychopathological profile of patients with vulvodynia: an observational and descriptive study.

Authors:  M J Tribó; O Andión; S Ros; M Gilaberte; F Gallardo; A Toll; M Ferrán; A Bulbena; R M Pujol; J E Baños
Journal:  Dermatology       Date:  2008       Impact factor: 5.366

8.  Prevalence of pain syndromes, mood conditions, and asthma in adolescents and young women with endometriosis.

Authors:  Noam Smorgick; Courtney A Marsh; Sawsan As-Sanie; Yolanda R Smith; Elisabeth H Quint
Journal:  J Pediatr Adolesc Gynecol       Date:  2013-03-16       Impact factor: 1.814

9.  Psychosocial phenotyping in women with interstitial cystitis/painful bladder syndrome: a case control study.

Authors:  J Curtis Nickel; Dean A Tripp; Michel Pontari; Robert Moldwin; Robert Mayer; Lesley K Carr; Raggi Doggweiler; Claire C Yang; Nagendra Mishra; Jorgen Nordling
Journal:  J Urol       Date:  2010-01       Impact factor: 7.450

10.  Feeling bad in more ways than one: comorbidity patterns of medically unexplained and psychiatric conditions.

Authors:  Ellen A Schur; Niloofar Afari; Helena Furberg; Megan Olarte; Jack Goldberg; Patrick F Sullivan; Dedra Buchwald
Journal:  J Gen Intern Med       Date:  2007-06       Impact factor: 5.128

View more
  21 in total

1.  Remission, Relapse, and Persistence of Vulvodynia: A Longitudinal Population-Based Study.

Authors:  Barbara D Reed; Sioban D Harlow; Melissa A Plegue; Ananda Sen
Journal:  J Womens Health (Larchmt)       Date:  2016-01-11       Impact factor: 2.681

2.  Recruitment methods in a clinical trial of provoked vulvodynia: Predictors of enrollment.

Authors:  Candi C Bachour; Gloria A Bachmann; David C Foster; Jim Y Wan; Leslie A Rawlinson; Candace S Brown
Journal:  Clin Trials       Date:  2016-08-11       Impact factor: 2.486

Review 3.  Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches.

Authors:  Natalie O Rosen; Samantha J Dawson; Melissa Brooks; Susan Kellogg-Spadt
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

4.  Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study.

Authors:  L Elaine Waetjen; Sybil L Crawford; Po-Yin Chang; Barbara D Reed; Rachel Hess; Nancy E Avis; Sioban D Harlow; Gail A Greendale; Sheila A Dugan; Ellen B Gold
Journal:  Menopause       Date:  2018-10       Impact factor: 2.953

5.  Does Degree of Vulvar Sensitivity Predict Vulvodynia Characteristics and Prognosis?

Authors:  Barbara D Reed; Melissa A Plegue; Siobán D Harlow; Hope K Haefner; Ananda Sen
Journal:  J Pain       Date:  2016-10-24       Impact factor: 5.820

6.  Vulvodynia and Irritable Bowel Syndrome Treated With an Elimination Diet: A Case Report.

Authors:  Jessica Drummond; Deborah Ford; Stephanie Daniel; Tara Meyerink
Journal:  Integr Med (Encinitas)       Date:  2016-08

7.  A Role for Bradykinin Signaling in Chronic Vulvar Pain.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Constantine G Haidaris; Richard P Phipps
Journal:  J Pain       Date:  2016-08-18       Impact factor: 5.820

8.  Vestibular Mast Cell Density in Vulvodynia: A Case-Controlled Study.

Authors:  Dimitrios Papoutsis; Hope K Haefner; Christopher P Crum; Anthony W Opipari; Barbara D Reed
Journal:  J Low Genit Tract Dis       Date:  2016-07       Impact factor: 1.925

9.  Environmental Exposure History and Vulvodynia Risk: A Population-Based Study.

Authors:  Barbara D Reed; Kimberly S McKee; Melissa A Plegue; Sung Kyun Park; Hope K Haefner; Sioban D Harlow
Journal:  J Womens Health (Larchmt)       Date:  2018-10-10       Impact factor: 2.681

Review 10.  A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation.

Authors:  M L Falsetta; D C Foster; A D Bonham; R P Phipps
Journal:  BJOG       Date:  2016-06-17       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.